SCIMECA, MANUEL
SCIMECA, MANUEL
Dipartimento di Medicina Sperimentale
18F-Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
2019-10-11 Urbano, N; Scimeca, M; Crocco, A; Mauriello, A; Bonanno, E; Schillaci, O
18F-FDG-PET/CT analysis in hospitalized patients affected by pulmonary disease: The experience of the Nuclear Medicine Unit of "policlinico Tor Vegata"
2021-01-01 Urbano, N; Scimeca, M; Tavolozza, M; Bonanno, E; Mauriello, A; Schillaci, O
99mTc sestamibi SPECT: A possible tool for early detection of breast cancer lesions with high bone metastatic potential
2019-02-01 Urbano, N; Scimeca, M; Bonanno, E; Schillaci, O
99mTC-sestamibi breast imaging: current status, new ideas and future perspectives
2022-01-01 Urbano, N; Scimeca, M; Tancredi, V; Bonanno, E; Schillaci, O
[99mTc]Sestamibi SPECT can predict proliferation Index, angiogenesis, and vascular invasion in parathyroid patients: a retrospective study
2020-07-13 Urbano, N; Scimeca, M; Di Russo, C; Mauriello, A; Bonanno, E; Schillaci, O
[99Tc]Sestamibi bioaccumulation induces apoptosis in prostate cancer cells: an in vitro study
2022-01-01 Urbano, N; Scimeca, M; Bonanno, E; Bonfiglio, R; Mauriello, A; Schillaci, O
A comprehensive molecular characterization of a claudin-low luminal B breast tumor
2024-08-16 Giovannini, S; Smirnov, A; Concetti, L; Scimeca, M; Mauriello, A; Bischof, J; Rovella, V; Melino, G; Buonomo, Oc; Candi, E; Bernassola, F
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib
2015-01-01 Graziani, G; Artuso, S; De Luca, A; Muzi, A; Rotili, D; Scimeca, M; Atzori, M; Ceci, C; Mai, A; Leonetti, C; Levati, L; Bonanno, E; Tentori, L; Caccuri, Am
A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts
2015-01-01 De Luca, A; Rotili, D; Carpanese, D; Lenoci, A; Calderan, L; Scimeca, M; Mai, A; Bonanno, E; Rosato, A; Geroni, C; Quintieri, L; Caccuri, Am; DE LUCA, A
A novel prostate cell type-specific gene signature to interrogate prostate tumor differentiation status and monitor therapeutic response (Running title: Phenotypic classification of prostate tumors)
2020-01-01 Mapelli, Sn; Albino, D; Mello-Grand, M; Shinde, D; Scimeca, M; Bonfiglio, R; Bonanno, E; Chiorino, G; Garcia-Escudero, R; Catapano, Cv; Carbone, Gm
A random initialization deep neural network for discriminating malignant breast cancer lesions
2019-01-01 Duggento, A; Scimeca, M; Urbano, N; Bonanno, E; Aiello, M; Cavaliere, C; Cascella, Gl; Cascella, D; Conte, G; Guerrisi, M; Toschi, N
Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding
2016-01-01 Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D’Atri, S; Lacal, P
Adjuvant denosumab in early breast cancer
2020-01-01 Scimeca, M; Bonfiglio, R; Urbano, N; Schillaci, O; Bonanno, E
Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies
2023-07-18 Yang, X; Wang, Y; Rovella, V; Candi, E; Jia, W; Bernassola, F; Bove, P; Piacentini, M; Scimeca, M; Sica, G; Tisone, G; Mauriello, A; Wei, L; Melino, G; Shi, Y
Aging
2012-01-01 Spagnoli, Lg; Mauriello, A; Orlandi, A; Scimeca, M; Volpe, A; Bonanno, E
Alleviating hypoxia to improve cancer immunotherapy
2023-10-26 Fan, P; Zhang, N; Candi, E; Agostini, M; Piacentini, M; Bernassola, F; Bove, P; Mauriello, A; Novelli, G; Rovella, V; Scimeca, M; Sica, G; Sun, Q; Tisone, G; Wang, Y; Shi, Y; Huang, Y; Melino, G
Animal models for the study of inflammatory bowel diseases: a meta-analysis on modalities for imaging inflammatory lesions
2018-03-01 Auletta, S; Bonfiglio, R; Wunder, A; Varani, M; Galli, F; Borri, F; Scimeca, M; Niessen, Hg; Schönberger, T; Bonanno, E
Antigenicity Preservation Is Related to Tissue Characteristics and the Post-Mortem Interval: Immunohistochemical Study and Literature Review
2022-01-01 Mauriello, S; Treglia, M; Pallocci, M; Bonfiglio, R; Giacobbi, E; Passalacqua, P; Cammarano, A; D'Ovidio, C; Marsella, Lt; Scimeca, M
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding
2016-01-01 Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D'Atri, S; Lacal, P
Assessment of metal contaminants in non-small cell lung cancer by EDX microanalysis
2014-01-01 Scimeca, M; Orlandi, A; Terrenato, I; Bischetti, S; Bonanno, E
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 11-ott-2019 | 18F-Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers | Urbano, N; Scimeca, M; Crocco, A; Mauriello, A; Bonanno, E; Schillaci, O | Articolo su rivista | |
| 1-gen-2021 | 18F-FDG-PET/CT analysis in hospitalized patients affected by pulmonary disease: The experience of the Nuclear Medicine Unit of "policlinico Tor Vegata" | Urbano, N; Scimeca, M; Tavolozza, M; Bonanno, E; Mauriello, A; Schillaci, O | Articolo su rivista | |
| 1-feb-2019 | 99mTc sestamibi SPECT: A possible tool for early detection of breast cancer lesions with high bone metastatic potential | Urbano, N; Scimeca, M; Bonanno, E; Schillaci, O | Articolo su rivista | |
| 1-gen-2022 | 99mTC-sestamibi breast imaging: current status, new ideas and future perspectives | Urbano, N; Scimeca, M; Tancredi, V; Bonanno, E; Schillaci, O | Articolo su rivista | |
| 13-lug-2020 | [99mTc]Sestamibi SPECT can predict proliferation Index, angiogenesis, and vascular invasion in parathyroid patients: a retrospective study | Urbano, N; Scimeca, M; Di Russo, C; Mauriello, A; Bonanno, E; Schillaci, O | Articolo su rivista | |
| 1-gen-2022 | [99Tc]Sestamibi bioaccumulation induces apoptosis in prostate cancer cells: an in vitro study | Urbano, N; Scimeca, M; Bonanno, E; Bonfiglio, R; Mauriello, A; Schillaci, O | Articolo su rivista | |
| 16-ago-2024 | A comprehensive molecular characterization of a claudin-low luminal B breast tumor | Giovannini, S; Smirnov, A; Concetti, L; Scimeca, M; Mauriello, A; Bischof, J; Rovella, V; Melino, G; Buonomo, Oc; Candi, E; Bernassola, F | Articolo su rivista | |
| 1-gen-2015 | A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib | Graziani, G; Artuso, S; De Luca, A; Muzi, A; Rotili, D; Scimeca, M; Atzori, M; Ceci, C; Mai, A; Leonetti, C; Levati, L; Bonanno, E; Tentori, L; Caccuri, Am | Articolo su rivista | |
| 1-gen-2015 | A novel orally active water-soluble inhibitor of human glutathione transferase exerts a potent and selective antitumor activity against human melanoma xenografts | De Luca, A; Rotili, D; Carpanese, D; Lenoci, A; Calderan, L; Scimeca, M; Mai, A; Bonanno, E; Rosato, A; Geroni, C; Quintieri, L; Caccuri, Am; DE LUCA, A | Articolo su rivista | |
| 1-gen-2020 | A novel prostate cell type-specific gene signature to interrogate prostate tumor differentiation status and monitor therapeutic response (Running title: Phenotypic classification of prostate tumors) | Mapelli, Sn; Albino, D; Mello-Grand, M; Shinde, D; Scimeca, M; Bonfiglio, R; Bonanno, E; Chiorino, G; Garcia-Escudero, R; Catapano, Cv; Carbone, Gm | Articolo su rivista | |
| 1-gen-2019 | A random initialization deep neural network for discriminating malignant breast cancer lesions | Duggento, A; Scimeca, M; Urbano, N; Bonanno, E; Aiello, M; Cavaliere, C; Cascella, Gl; Cascella, D; Conte, G; Guerrisi, M; Toschi, N | Contributo in libro | |
| 1-gen-2016 | Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding | Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D’Atri, S; Lacal, P | Intervento a convegno | |
| 1-gen-2020 | Adjuvant denosumab in early breast cancer | Scimeca, M; Bonfiglio, R; Urbano, N; Schillaci, O; Bonanno, E | Articolo su rivista | |
| 18-lug-2023 | Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies | Yang, X; Wang, Y; Rovella, V; Candi, E; Jia, W; Bernassola, F; Bove, P; Piacentini, M; Scimeca, M; Sica, G; Tisone, G; Mauriello, A; Wei, L; Melino, G; Shi, Y | Articolo su rivista | |
| 1-gen-2012 | Aging | Spagnoli, Lg; Mauriello, A; Orlandi, A; Scimeca, M; Volpe, A; Bonanno, E | Contributo in libro | |
| 26-ott-2023 | Alleviating hypoxia to improve cancer immunotherapy | Fan, P; Zhang, N; Candi, E; Agostini, M; Piacentini, M; Bernassola, F; Bove, P; Mauriello, A; Novelli, G; Rovella, V; Scimeca, M; Sica, G; Sun, Q; Tisone, G; Wang, Y; Shi, Y; Huang, Y; Melino, G | Articolo su rivista | |
| 1-mar-2018 | Animal models for the study of inflammatory bowel diseases: a meta-analysis on modalities for imaging inflammatory lesions | Auletta, S; Bonfiglio, R; Wunder, A; Varani, M; Galli, F; Borri, F; Scimeca, M; Niessen, Hg; Schönberger, T; Bonanno, E | Articolo su rivista | |
| 1-gen-2022 | Antigenicity Preservation Is Related to Tissue Characteristics and the Post-Mortem Interval: Immunohistochemical Study and Literature Review | Mauriello, S; Treglia, M; Pallocci, M; Bonfiglio, R; Giacobbi, E; Passalacqua, P; Cammarano, A; D'Ovidio, C; Marsella, Lt; Scimeca, M | Articolo su rivista | |
| 1-gen-2016 | Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding | Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D'Atri, S; Lacal, P | Articolo su rivista | |
| 1-gen-2014 | Assessment of metal contaminants in non-small cell lung cancer by EDX microanalysis | Scimeca, M; Orlandi, A; Terrenato, I; Bischetti, S; Bonanno, E | Articolo su rivista |